Discovery of a novel potent cytochrome P450 CYP4Z1 inhibitor
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference61 articles.
1. Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma;Rieger;Canc. Res.,2004
2. Systematic variation in gene expression patterns in human cancer cell lines;Ross;Nat. Genet.,2000
3. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen;Ma;Canc. Cell,2004
4. Profiling the expression of cytochrome P450 in breast cancer;Murray;Histopathology,2010
5. Endogenous human microRNAs that suppress breast cancer metastasis;Tavazoie;Nature,2008
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. There and Back Again: A Perspective on 20 Years of CYP4Z1;Drug Metabolism and Disposition;2024-04-11
2. 1‐Benzylimidazole attenuates the stemness of breast cancer cells through partially targeting CYP4Z1;Environmental Toxicology;2023-11-23
3. Development of an efficient insecticide substrate and inhibitor screening system of insect P450s using fission yeast;Insect Biochemistry and Molecular Biology;2023-06
4. Exploring human CYP4 enzymes: Physiological roles, function in diseases and focus on inhibitors;Drug Discovery Today;2023-05
5. Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization;J MED CHEM;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3